BioNTech Inks $250M Deal with Autolus to Advance CAR T Assets | BioSpace

Retrieved on: 2024-02-08 16:17:54

Tags for this article:

BioNTech

Medical research

COVID-19 vaccination in the United States

Pfizer-BioNTech COVID-19 vaccine

Uğur Şahin

CAR T cell

Autolus

Click the tags to see associated articles and topics

BioNTech Inks $250M Deal with Autolus to Advance CAR T Assets | BioSpace. View article details on HISWAI: https://www.biospace.com/article/biontech-inks-200m-deal-with-autolus-to-advance-car-t-asset/

Excerpt

... monoclonal antibodies. However, the details of the antibodies' therapeutic target were not revealed at the time. Tyler Patchen is a staff writer ...

Article found on: www.biospace.com

View Original Article